Vanguard Group Inc United Therapeutics Corp Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Vanguard Group Inc holds 4,441,823 shares of UTHR stock, worth $1.6 Billion. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,441,823

Previous 4,409,610 0.73%

Holding current value

$1.6 Billion

Previous $1.58 Billion 0.82%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$348.66 - $410.0 $11.2 Million - $13.2 Million	32,213 Added 0.73%	4,441,823 $1.57 Billion
Q3 2024 Nov 13, 2024	SELL	$311.04 - $363.55 $2.91 Million - $3.4 Million	-9,353 Reduced 0.21%	4,409,610 $1.58 Billion
Q2 2024 Aug 13, 2024	SELL	$228.26 - $319.04 $60.3 Million - $84.3 Million	-264,132 Reduced 5.64%	4,418,963 $1.41 Billion
Q1 2024 May 10, 2024	BUY	$210.76 - $249.51 $1.98 Million - $2.35 Million	9,417 Added 0.2%	4,683,095 $1.08 Billion
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $2.31 Million - $2.77 Million	10,767 Added 0.23%	4,673,678 $1.03 Billion
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $4.32 Million - $5.06 Million	20,373 Added 0.44%	4,662,911 $1.05 Billion
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $7.51 Million - $8.53 Million	36,621 Added 0.8%	4,642,538 $1.02 Billion
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $26.7 Million - $34.6 Million	125,198 Added 2.79%	4,605,917 $1.03 Billion
Q4 2022 Feb 10, 2023	BUY	$205.95 - $280.43 $14.2 Million - $19.4 Million	69,103 Added 1.57%	4,480,719 $1.25 Billion
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $33.2 Million - $39.9 Million	163,542 Added 3.85%	4,411,616 $924 Million
Q2 2022 Aug 12, 2022	BUY	$174.81 - $241.14 $13.9 Million - $19.1 Million	79,278 Added 1.9%	4,248,074 $1 Billion
Q1 2022 May 13, 2022	BUY	$166.16 - $213.96 $1.3 Million - $1.68 Million	7,833 Added 0.19%	4,168,796 $748 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $128,102 - $150,175	695 Added 0.02%	4,160,963 $899 Million
Q3 2021 Nov 12, 2021	SELL	$179.86 - $214.88 $7.1 Million - $8.48 Million	-39,473 Reduced 0.94%	4,160,268 $768 Million
Q2 2021 Aug 13, 2021	BUY	$170.47 - $211.93 $716 Million - $890 Million	4,199,741 New	4,199,741 $753 Million

Others Institutions Holding UTHR

# of Institutions

723

Shares Held

60.9M

Call Options Held

123K

Put Options Held

104K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc United Therapeutics Corp Transaction History